Global and United States Clinical Oncology Next Generation Sequencing (NGS) Market Report & Forecast 2022-2028

Global and United States Clinical Oncology Next Generation Sequencing (NGS) Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Clinical Oncology Next Generation Sequencing (NGS) Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Introduction
1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size for the Year 2017-2028
1.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size for the Year 2017-2028
1.3 Clinical Oncology Next Generation Sequencing (NGS) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Clinical Oncology Next Generation Sequencing (NGS) in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Clinical Oncology Next Generation Sequencing (NGS) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Clinical Oncology Next Generation Sequencing (NGS) Market Dynamics
1.4.1 Clinical Oncology Next Generation Sequencing (NGS) Industry Trends
1.4.2 Clinical Oncology Next Generation Sequencing (NGS) Market Drivers
1.4.3 Clinical Oncology Next Generation Sequencing (NGS) Market Challenges
1.4.4 Clinical Oncology Next Generation Sequencing (NGS) Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Clinical Oncology Next Generation Sequencing (NGS) by Type
2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Segment by Type
2.1.1 NGS Pre-Sequencing
2.1.2 Sequencing
2.1.3 NGS Data Analysis
2.1.4 Primary, Secondary & Tertiary Data Analysis
2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2017, 2022 & 2028)
2.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2017-2028)
2.4 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2017, 2022 & 2028)
2.5 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2017-2028)
3 Clinical Oncology Next Generation Sequencing (NGS) by Application
3.1 Clinical Oncology Next Generation Sequencing (NGS) Market Segment by Application
3.1.1 Academic & Clinical Research
3.1.2 Hospitals & Clinics
3.1.3 Pharma & Biotech Entities
3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2017, 2022 & 2028)
3.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2017-2028)
3.4 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2017, 2022 & 2028)
3.5 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2017-2028)
4 Global Clinical Oncology Next Generation Sequencing (NGS) Competitor Landscape by Company
4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Company
4.1.1 Top Global Clinical Oncology Next Generation Sequencing (NGS) Companies Ranked by Revenue (2021)
4.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Player (2017-2022)
4.2 Global Clinical Oncology Next Generation Sequencing (NGS) Concentration Ratio (CR)
4.2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Clinical Oncology Next Generation Sequencing (NGS) in 2021
4.2.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Clinical Oncology Next Generation Sequencing (NGS) Headquarters, Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Type
4.3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Headquarters and Area Served
4.3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Companies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Clinical Oncology Next Generation Sequencing (NGS) Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Company
4.5.1 Top Clinical Oncology Next Generation Sequencing (NGS) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Clinical Oncology Next Generation Sequencing (NGS) Revenue by Players (2020, 2021 & 2022)
5 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region
5.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2017-2028)
5.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region: 2017-2022
5.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth 2017-2028
6.1.2 North America Clinical Oncology Next Generation Sequencing (NGS) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth 2017-2028
6.3.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth 2017-2028
6.4.2 Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Illumina
7.1.1 Illumina Company Details
7.1.2 Illumina Business Overview
7.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.1.4 Illumina Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.1.5 Illumina Recent Development
7.2 Roche
7.2.1 Roche Company Details
7.2.2 Roche Business Overview
7.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.2.4 Roche Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.2.5 Roche Recent Development
7.3 Agilent Technologies
7.3.1 Agilent Technologies Company Details
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.3.4 Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.3.5 Agilent Technologies Recent Development
7.4 Knome
7.4.1 Knome Company Details
7.4.2 Knome Business Overview
7.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.4.4 Knome Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.4.5 Knome Recent Development
7.5 Genomatix Software
7.5.1 Genomatix Software Company Details
7.5.2 Genomatix Software Business Overview
7.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.5.4 Genomatix Software Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.5.5 Genomatix Software Recent Development
7.6 GATC Biotech
7.6.1 GATC Biotech Company Details
7.6.2 GATC Biotech Business Overview
7.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.6.4 GATC Biotech Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.6.5 GATC Biotech Recent Development
7.7 Oxford Nanopore Technologies
7.7.1 Oxford Nanopore Technologies Company Details
7.7.2 Oxford Nanopore Technologies Business Overview
7.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.7.4 Oxford Nanopore Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.7.5 Oxford Nanopore Technologies Recent Development
7.8 Macrogen
7.8.1 Macrogen Company Details
7.8.2 Macrogen Business Overview
7.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.8.4 Macrogen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.8.5 Macrogen Recent Development
7.9 Life Technologies
7.9.1 Life Technologies Company Details
7.9.2 Life Technologies Business Overview
7.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.9.4 Life Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.9.5 Life Technologies Recent Development
7.10 DNASTAR
7.10.1 DNASTAR Company Details
7.10.2 DNASTAR Business Overview
7.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.10.4 DNASTAR Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.10.5 DNASTAR Recent Development
7.11 Exosome Diagnostics
7.11.1 Exosome Diagnostics Company Details
7.11.2 Exosome Diagnostics Business Overview
7.11.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.11.4 Exosome Diagnostics Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.11.5 Exosome Diagnostics Recent Development
7.12 Biomatters
7.12.1 Biomatters Company Details
7.12.2 Biomatters Business Overview
7.12.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.12.4 Biomatters Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.12.5 Biomatters Recent Development
7.13 CLC Bio
7.13.1 CLC Bio Company Details
7.13.2 CLC Bio Business Overview
7.13.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.13.4 CLC Bio Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.13.5 CLC Bio Recent Development
7.14 BGI
7.14.1 BGI Company Details
7.14.2 BGI Business Overview
7.14.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.14.4 BGI Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.14.5 BGI Recent Development
7.15 Qiagen
7.15.1 Qiagen Company Details
7.15.2 Qiagen Business Overview
7.15.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.15.4 Qiagen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.15.5 Qiagen Recent Development
7.16 Perkin Elmer
7.16.1 Perkin Elmer Company Details
7.16.2 Perkin Elmer Business Overview
7.16.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.16.4 Perkin Elmer Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.16.5 Perkin Elmer Recent Development
7.17 Pacific Bioscience
7.17.1 Pacific Bioscience Company Details
7.17.2 Pacific Bioscience Business Overview
7.17.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.17.4 Pacific Bioscience Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.17.5 Pacific Bioscience Recent Development
7.18 Partek
7.18.1 Partek Company Details
7.18.2 Partek Business Overview
7.18.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.18.4 Partek Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.18.5 Partek Recent Development
7.19 GnuBIO
7.19.1 GnuBIO Company Details
7.19.2 GnuBIO Business Overview
7.19.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.19.4 GnuBIO Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.19.5 GnuBIO Recent Development
7.20 Foundation Medicine
7.20.1 Foundation Medicine Company Details
7.20.2 Foundation Medicine Business Overview
7.20.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.20.4 Foundation Medicine Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.20.5 Foundation Medicine Recent Development
7.21 Paradigm
7.21.1 Paradigm Company Details
7.21.2 Paradigm Business Overview
7.21.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.21.4 Paradigm Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.21.5 Paradigm Recent Development
7.22 Caris Life Sciences
7.22.1 Caris Life Sciences Company Details
7.22.2 Caris Life Sciences Business Overview
7.22.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.22.4 Caris Life Sciences Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.22.5 Caris Life Sciences Recent Development
7.23 Myriad Genetics
7.23.1 Myriad Genetics Company Details
7.23.2 Myriad Genetics Business Overview
7.23.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Introduction
7.23.4 Myriad Genetics Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022)
7.23.5 Myriad Genetics Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Clinical Oncology Next Generation Sequencing (NGS) Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Clinical Oncology Next Generation Sequencing (NGS) Market Trends
Table 3. Clinical Oncology Next Generation Sequencing (NGS) Market Drivers
Table 4. Clinical Oncology Next Generation Sequencing (NGS) Market Challenges
Table 5. Clinical Oncology Next Generation Sequencing (NGS) Market Restraints
Table 6. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Clinical Oncology Next Generation Sequencing (NGS) Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Player, 2017-2022
Table 13. Global Clinical Oncology Next Generation Sequencing (NGS) Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Clinical Oncology Next Generation Sequencing (NGS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Oncology Next Generation Sequencing (NGS) as of 2021)
Table 15. Top Players of Clinical Oncology Next Generation Sequencing (NGS) in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Clinical Oncology Next Generation Sequencing (NGS) Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Clinical Oncology Next Generation Sequencing (NGS) Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Clinical Oncology Next Generation Sequencing (NGS) Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Clinical Oncology Next Generation Sequencing (NGS) Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Clinical Oncology Next Generation Sequencing (NGS) Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Illumina Company Details
Table 31. Illumina Business Overview
Table 32. Illumina Clinical Oncology Next Generation Sequencing (NGS) Product
Table 33. Illumina Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 34. Illumina Recent Development
Table 35. Roche Company Details
Table 36. Roche Business Overview
Table 37. Roche Clinical Oncology Next Generation Sequencing (NGS) Product
Table 38. Roche Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 39. Roche Recent Development
Table 40. Agilent Technologies Company Details
Table 41. Agilent Technologies Business Overview
Table 42. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product
Table 43. Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 44. Agilent Technologies Recent Development
Table 45. Knome Company Details
Table 46. Knome Business Overview
Table 47. Knome Clinical Oncology Next Generation Sequencing (NGS) Product
Table 48. Knome Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 49. Knome Recent Development
Table 50. Genomatix Software Company Details
Table 51. Genomatix Software Business Overview
Table 52. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product
Table 53. Genomatix Software Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 54. Genomatix Software Recent Development
Table 55. GATC Biotech Company Details
Table 56. GATC Biotech Business Overview
Table 57. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product
Table 58. GATC Biotech Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 59. GATC Biotech Recent Development
Table 60. Oxford Nanopore Technologies Company Details
Table 61. Oxford Nanopore Technologies Business Overview
Table 62. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product
Table 63. Oxford Nanopore Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 64. Oxford Nanopore Technologies Recent Development
Table 65. Macrogen Company Details
Table 66. Macrogen Business Overview
Table 67. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product
Table 68. Macrogen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 69. Macrogen Recent Development
Table 70. Life Technologies Company Details
Table 71. Life Technologies Business Overview
Table 72. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product
Table 73. Life Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 74. Life Technologies Recent Development
Table 75. DNASTAR Company Details
Table 76. DNASTAR Business Overview
Table 77. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product
Table 78. DNASTAR Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 79. DNASTAR Recent Development
Table 80. Exosome Diagnostics Company Details
Table 81. Exosome Diagnostics Business Overview
Table 82. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product
Table 83. Exosome Diagnostics Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 84. Exosome Diagnostics Recent Development
Table 85. Biomatters Company Details
Table 86. Biomatters Business Overview
Table 87. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product
Table 88. Biomatters Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 89. Biomatters Recent Development
Table 90. CLC Bio Company Details
Table 91. CLC Bio Business Overview
Table 92. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product
Table 93. CLC Bio Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 94. CLC Bio Recent Development
Table 95. BGI Company Details
Table 96. BGI Business Overview
Table 97. BGI Clinical Oncology Next Generation Sequencing (NGS) Product
Table 98. BGI Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 99. BGI Recent Development
Table 100. Qiagen Company Details
Table 101. Qiagen Business Overview
Table 102. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product
Table 103. Qiagen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 104. Qiagen Recent Development
Table 105. Perkin Elmer Company Details
Table 106. Perkin Elmer Business Overview
Table 107. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product
Table 108. Perkin Elmer Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 109. Perkin Elmer Recent Development
Table 110. Pacific Bioscience Company Details
Table 111. Pacific Bioscience Business Overview
Table 112. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product
Table 113. Pacific Bioscience Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 114. Pacific Bioscience Recent Development
Table 115. Partek Company Details
Table 116. Partek Business Overview
Table 117. Partek Clinical Oncology Next Generation Sequencing (NGS) Product
Table 118. Partek Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 119. Partek Recent Development
Table 120. GnuBIO Company Details
Table 121. GnuBIO Business Overview
Table 122. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product
Table 123. GnuBIO Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 124. GnuBIO Recent Development
Table 125. Foundation Medicine Company Details
Table 126. Foundation Medicine Business Overview
Table 127. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product
Table 128. Foundation Medicine Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 129. Foundation Medicine Recent Development
Table 130. Paradigm Company Details
Table 131. Paradigm Business Overview
Table 132. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product
Table 133. Paradigm Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 134. Paradigm Recent Development
Table 135. Caris Life Sciences Company Details
Table 136. Caris Life Sciences Business Overview
Table 137. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product
Table 138. Caris Life Sciences Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 139. Caris Life Sciences Recent Development
Table 140. Myriad Genetics Company Details
Table 141. Myriad Genetics Business Overview
Table 142. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product
Table 143. Myriad Genetics Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million)
Table 144. Myriad Genetics Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Clinical Oncology Next Generation Sequencing (NGS) Product Picture
Figure 2. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size 2017-2028 (US$ Million)
Figure 4. United States Clinical Oncology Next Generation Sequencing (NGS) Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Clinical Oncology Next Generation Sequencing (NGS) Market Size 2017-2028 (US$ Million)
Figure 6. United States Clinical Oncology Next Generation Sequencing (NGS) Market Share in Global 2017-2028
Figure 7. Clinical Oncology Next Generation Sequencing (NGS) Report Years Considered
Figure 8. Product Picture of NGS Pre-Sequencing
Figure 9. Product Picture of Sequencing
Figure 10. Product Picture of NGS Data Analysis
Figure 11. Product Picture of Primary, Secondary & Tertiary Data Analysis
Figure 12. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type in 2022 & 2028
Figure 13. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2017-2028)
Figure 15. United States Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type in 2022 & 2028
Figure 16. United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2017-2028)
Figure 18. Product Picture of Academic & Clinical Research
Figure 19. Product Picture of Hospitals & Clinics
Figure 20. Product Picture of Pharma & Biotech Entities
Figure 21. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application in 2022 & 2028
Figure 22. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2017-2028)
Figure 24. United States Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application in 2022 & 2028
Figure 25. United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2017-2028)
Figure 27. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. U.S. Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Taiwan Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Philippines Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47.

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs